Orchestra BioMed Holdings Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -37.5% | +136.6% | +25.5% | +26.9% | -74.4% | +243.1% | -3.7% | +3.0% | +3,490.8% | -99.6% | -20.0% | – | |
| – | +102.4% | +30.1% | -59.3% | +54.5% | -14.7% | -24.1% | +4.5% | +6.5% | +4.1% | +80.4% | -72.8% | – | |
| – | -52.6% | +186.0% | +43.4% | +25.2% | -78.8% | +322.6% | -4.1% | +2.8% | +3,701.2% | -99.9% | +250.0% | – | |
| – | -0.5% | +7.1% | +22.1% | +4.2% | -5.4% | +22.9% | +2.8% | +1.3% | +19.9% | -6.2% | +5.1% | – | |
| – | -34.0% | +40.9% | +9.7% | -12.4% | +4.1% | +6.1% | +0.0% | +13.3% | +2.7% | -12.6% | -8.5% | – | |
| – | -15.0% | +18.0% | +17.8% | -1.9% | -2.3% | +17.0% | +1.9% | +5.0% | +14.1% | -8.4% | +1.5% | – | |
| – | – | – | – | – | – | – | – | – | – | -426.9% | – | – | |
| – | – | – | – | – | – | – | – | +1,330.6% | +48.2% | +7.6% | +115.3% | – | |
| – | – | – | – | – | – | – | – | – | – | -431.3% | – | – | |
| – | – | -98.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -431.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | -379.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.